Additionally, in a previous study from our research group of patients with diffuse large B-cell lymphoma (DLBCL), we found that the high expression of MYC and BCL2 by IHC was more often observed in patients with abdominal lymph node involvement, compared to patients without abdominal lymph node involvement [35]. Here, BCL2 is linked to diffuse large B-cell lymphoma.